Anthem Biosciences IPO: Check Day One Subscription Status, GMP, Price Band And More

The mainboard initial public offering of technology-driven drug manufacturer Anthem Biosciences Ltd. opened on July 14 and will close on July 16. The price band for the IPO has been fixed at Rs 540 to Rs 570 per share of face value of Rs 2 each.

The IPO is a bookbuilding issue of Rs 3,395.00 crore. The issue is entirely an offer for sale of 5.96 crore shares, from its promoters, investors, and other selling shareholders. The shareholders are offloading their stake. Since this IPO is fully an OFS, the company will not receive any funds, and all earnings will be directed to the selling shareholders.

Anthem Biosciences is an innovation-driven and technology-focused contract research, development, and manufacturing organisation, with integrated operations encompassing drug discovery, development, and manufacturing processes.

The company serves customers, including emerging biotech firms and large pharmaceutical companies on a global scale. It manufactures specialised fermentation-based APIs, including probiotics, enzymes, peptides, nutritional actives, vitamin analogues, and biosimilars.

JM Financial Ltd, Citigroup Global Markets India, J P Morgan India and Nomura Financial Advisory and Securities (India) Pvt. are the book-running lead managers for the issue, while KFin Technologies is the registrar.

• Issue opens: July 14.

• Issue closes: July 16.

• Issue price band: Rs 540 and Rs 570 per share.

• Lot size: 26 shares.

• Total issue size: Rs 3,395 crore.

• Type: Book-building issue.

• Tentative listing date: July 17.

The issue has been subscribed 0.18 times or 18% as of 11:57 a.m.

• Qualified institutional buyers: Nil.

• Non-institutional buyers: 0.33 times or 33%.

• Retail investors: 0.21 times or 21%.

• Portion reserved for employees: 0.35 times or 35%.

The grey market premium for Anthem Biosciences IPO stood at Rs 109, as of 11:58 a.m. on July 14, according to InvestorGain. That implies listing at a premium.

GMP or grey market price is not an official indicator and is based on market speculation.